WEST Women's Health Panel: Innovation and Investment—Is the Tide Turning?

Please register through the WEST website here.

Join WEST for an insightful and interactive panel discussion exploring the latest advancements and investments in women's health. Building off last year's momentum around women's health, we are hosting a panel that will focus on real-world innovations shaping the future of healthcare for women. Our expert panelists spanning biotech and investment will dive into key innovation areas such as cardiovascular disease, oncology, and autoimmune disorders.
We’ll discuss groundbreaking research and how the investment landscape is evolving in regards to women’s health. Don’t miss this opportunity to gain valuable insights to close the gap, hear from industry leaders, and explore where the future of women's health is headed.
Let's discuss the progress and potential in women’s health!
Speakers and panelists to include:

• Farnaz Bakhshi, Director, Innovation, BrightEdge - American Cancer Society
• Megan Greenfield, Partner, McKinsey & Affiliated Leader, McKinsey Health Institute, McKinsey & Company
• Rachel Greenfield, Manager - Lilly Gateway Labs | External Innovation, Eli Lilly and Company
• Carla Klattenhoff, Senior Director/ Scientific US Lead for Research and Early Development in CV, Renal and Immunology, Bayer
• Cynthia Pussinen, CEO, Spes Bio
• Kathryn Rexrode, Chief Academic Officer, Brigham and Women's Hospital
• Karen Lackey, CEO, X-Chem, Panel Moderator

Date and Time:
June 24, 2025
5:00 - 7:00 PM ET
Agenda
5:00 - 5:30 PM Welcome, Presentation
5:30 - 6:15 PM Panel Discussion
6:15 - 6:30 PM Q&A
6:30 - 7:00 PM Networking

Location:
Bayer CoLab, 238 Main St., Cambridge, MA 02142
Cost:
Members: $0; Non-Members: $10